Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ACET | Adicet Bio, Inc.

Index	RUT	P/E	-	EPS (ttm)	-2.70	Insider Own	0.70%	Shs Outstand	42.96M	Perf Week	-3.61%
Market Cap	72.14M	Forward P/E	-	EPS next Y	-2.75	Insider Trans	-	Shs Float	41.80M	Perf Month	-15.34%
Income	-115.20M	PEG	-	EPS next Q	-0.74	Inst Own	96.07%	Short Float / Ratio	6.45% / 2.87	Perf Quarter	-65.37%
Sales	0.00M	P/S	-	EPS this Y	15.20%	Inst Trans	9.40%	Short Interest	2.70M	Perf Half Y	-75.65%
Book/sh	5.57	P/B	0.29	EPS next Y	6.80%	ROA	-36.30%	Target Price	20.33	Perf Year	-88.64%
Cash/sh	4.56	P/C	0.35	EPS next 5Y	29.10%	ROE	-41.30%	52W Range	1.60 - 21.87	Perf YTD	-82.10%
Dividend	-	P/FCF	-	EPS past 5Y	27.40%	ROI	-24.80%	52W High	-92.68%	Beta	1.98
Dividend %	-	Quick Ratio	11.10	Sales past 5Y	-	Gross Margin	-	52W Low	0.00%	ATR	0.14
Employees	132	Current Ratio	11.10	Sales Q/Q	-	Oper. Margin	-	RSI (14)	35.32	Volatility	7.75% 6.99%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	-34.10%	Profit Margin	-	Rel Volume	0.21	Prev Close	1.70
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Aug 09 AMC	Payout	-	Avg Volume	939.25K	Price	1.60
Recom	2.00	SMA20	-8.91%	SMA50	-28.43%	SMA200	-73.67%	Volume	195,825	Change	-5.88%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-27-23	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Jun-27-23	Downgrade	Guggenheim	Buy → Neutral
Jun-01-23	Downgrade	JP Morgan	Overweight → Neutral	$20 → $6
Sep-21-22	Initiated	JP Morgan	Overweight	$23
Mar-31-22	Initiated	SMBC Nikko	Outperform	$28
Mar-08-22	Initiated	Truist	Buy	$30
Mar-04-22	Initiated	Jefferies	Buy	$27
May-18-21	Initiated	BTIG Research	Buy	$34
Apr-23-21	Initiated	H.C. Wainwright	Buy	$27
Apr-14-21	Initiated	Canaccord Genuity	Buy	$28
Apr-08-21	Initiated	Guggenheim	Buy	$22
Nov-04-20	Initiated	B. Riley Securities	Buy	$30
Oct-27-20	Initiated	JMP Securities	Mkt Outperform	$30
Oct-16-20	Initiated	Wedbush	Outperform	$25

Show Previous Ratings

Aug-31-23 04:35PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +11.11%
Aug-12-23 08:16AM	Will Adicet Bio (NASDAQ:ACET) Spend Its Cash Wisely? (Simply Wall St.)
Aug-09-23 04:15PM	Adicet Reports Second Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Aug-02-23 04:00PM	Adicet Bio to Participate in a Fireside Chat at the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-31-23 04:50PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
08:30AM	Loading…
Jul-11-23 08:30AM	Adicet Announces Appointment of Katie Peng to the Board of Directors (Business Wire)
Jun-30-23 04:51PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.19%
Jun-26-23 04:00PM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Jun-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference (Business Wire) -5.20%
May-31-23 04:53PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-18-23 06:00AM	Adicet Bio Presents Positive Preclinical Data on ADI-270 at the American Society of Gene and Cell Therapy (ASGCT) 26th Annual Meeting (Business Wire)
May-09-23 04:30PM	Adicet Bio to Present at the 2023 JMP Securities Life Sciences Conference (Business Wire)
04:10PM	Adicet Reports First Quarter 2023 Financial Results and Provides Business Updates (Business Wire)
Apr-28-23 05:13PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-26-23 08:01PM	7 Biotech Stocks With Huge Return Potential for Long-Term Investors (InvestorPlace)
06:58AM	Loading…
Apr-17-23 06:58AM	Adicet Bio, Inc.'s (NASDAQ:ACET) Price Is Out Of Tune With Revenues (Simply Wall St.) +9.45%
Apr-13-23 07:00AM	Adicet Bio to Participate in 2023 Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire) +9.68%
Apr-04-23 02:47PM	Down More Than 60%: Analysts Say Buy These 3 Beaten-Down Stocks Before They Rebound (TipRanks) -6.14%
Mar-31-23 04:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-15-23 04:01PM	Adicet Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
11:44AM	7 Biotech Stocks That Could Be the Next Big Thing (InvestorPlace)
Mar-09-23 07:00AM	Adicet Bio to Participate in 2023 Jefferies Biotech on the Bay Summit (Business Wire)
Mar-05-23 07:09AM	Adicet Bio (NASDAQ:ACET) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Feb-28-23 05:31PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-01-23 07:00AM	Adicet Bio to Participate in a Fireside Chat at the 2023 Guggenheim Oncology Conference (Business Wire)
Jan-31-23 08:40PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.29%
Dec-30-22 04:43PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-20-22 08:23AM	Shareholders in Adicet Bio (NASDAQ:ACET) have lost 49%, as stock drops 22% this past week (Simply Wall St.)
Dec-10-22 10:00AM	Adicet Bio Reports Positive Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
Dec-02-22 07:00AM	Adicet Bio to Host Investor Webcast to Discuss Updated Clinical Data from Ongoing ADI-001 Phase 1 Trial in Patients with Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire)
08:08PM	Loading…
Nov-30-22 08:08PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
04:00PM	Adicet Bio to Present at the Virtual JMP Securities Hematology and Oncology Summit (Business Wire)
Nov-29-22 07:00AM	Adicet Bio Appoints Nancy Boman, M.D., Ph.D., as Senior Vice President and Chief Regulatory Officer (Business Wire) +6.41%
Nov-11-22 05:24AM	Adicet Bio Third Quarter 2022 Earnings: US$0.53 loss per share (vs US$0.44 loss in 3Q 2021) (Simply Wall St.)
Nov-08-22 04:10PM	Adicet Reports Third Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Nov-07-22 08:00AM	Adicet Bio Showcases Preclinical Data for Four New Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire) +7.22%
Nov-03-22 09:00AM	Adicet Bio Reports ASH Abstract Data from Ongoing ADI-001 Phase 1 Trial in Relapsed or Refractory Aggressive B-Cell Non-Hodgkins Lymphoma (NHL) (Business Wire) +5.16%
Nov-01-22 07:00AM	Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference (Business Wire)
Oct-31-22 06:58PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-23-22 08:39AM	Calculating The Intrinsic Value Of Adicet Bio, Inc. (NASDAQ:ACET) (Simply Wall St.)
Oct-05-22 08:00AM	Adicet Bio to Present Preclinical Data from Allogeneic Gamma Delta T Cell Pipeline Programs at The Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting (Business Wire)
Sep-30-22 06:59PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.88%
Sep-26-22 06:26AM	We're Hopeful That Adicet Bio (NASDAQ:ACET) Will Use Its Cash Wisely (Simply Wall St.)
Sep-07-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Aug-31-22 05:30PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-16-22 06:16AM	The Consensus EPS Estimates For Adicet Bio, Inc. (NASDAQ:ACET) Just Fell Dramatically (Simply Wall St.) -8.67%
Aug-10-22 07:00AM	Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
Aug-01-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jul-29-22 06:05PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-01-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jun-21-22 04:10PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire)
Jun-06-22 07:00AM	Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting (Business Wire) +6.61%
Jun-03-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
May-26-22 05:00PM	Adicet Bio Reports Positive Clinical Update from ADI-001 Phase 1 Trial in Relapsed/Refractory Non-Hodgkins Lymphoma (NHL) (Business Wire)
May-18-22 04:00PM	Adicet Bio to Present at Upcoming Investor Conferences (Business Wire) -12.42%
May-15-22 08:21AM	Results: Adicet Bio, Inc. Confounded Analyst Expectations With A Surprise Profit (Simply Wall St.)
May-12-22 04:10PM	Adicet Reports First Quarter 2022 Financial Results and Provides Business Updates (Business Wire)
11:14AM	Further weakness as Adicet Bio (NASDAQ:ACET) drops 31% this week, taking one-year losses to 17% (Simply Wall St.)
May-05-22 07:00AM	Adicet Presents Preclinical Data at the ISCT Annual Meeting Highlighting Potential Advantages of the Non-Gene-Edited Approach for its Investigational Allogeneic Gamma Delta CAR T Cell Therapy Targeting CD20 for B Cell Malignancies (Business Wire)
May-04-22 04:10PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-27-22 10:00AM	Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire) +6.78%
Apr-19-22 07:00AM	Adicet Bio Receives FDA Fast Track Designation for Lead Candidate ADI-001 (Business Wire)
Apr-07-22 04:10PM	Adicet Bio to Participate in Upcoming Investor Conferences (Business Wire)
Apr-01-22 04:10PM	Adicet Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-22-22 12:47PM	The Biotech Sector Nears an Inflection Point; Analysts Offer 3 Stocks to Consider (TipRanks) +10.85%
Mar-15-22 04:00PM	Adicet Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Company Progress (Business Wire) +5.53%
07:25AM	Here's Why We're Not Too Worried About Adicet Bio's (NASDAQ:ACET) Cash Burn Situation (Simply Wall St.)
Mar-04-22 04:00PM	Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Feb-02-22 07:00AM	Adicet Bio to Participate in Guggenheim 2022 Oncology Conference (Business Wire)
Dec-10-21 04:01PM	Adicet Bio, Inc. Announces Closing of $100 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares (GlobeNewswire)
Dec-09-21 05:49PM	How a biotech is turning 'road bikes' into 'mountain bikes' to roll over cancer (American City Business Journals) -10.14%
Dec-08-21 01:13AM	Adicet Bio, Inc. Announces Pricing of Public Offering of Common Stock (GlobeNewswire) +5.52%
Dec-07-21 04:16PM	Adicet Bio, Inc. Announces Proposed Follow-On Offering of Common Stock (GlobeNewswire) +6.78%
Dec-06-21 07:00AM	Adicet Bio Announces Positive Interim Clinical Data From First-Ever Allogeneic, Off-The-Shelf, Gamma Delta CAR T Investigational Cell Therapy (GlobeNewswire) +38.47%
Nov-29-21 07:00AM	Adicet Bio to Host Webcast Presentation of ADI-001 Interim Clinical Data in B Cell Non-Hodgkins Lymphoma (GlobeNewswire)
Nov-20-21 06:00AM	Adicet Bio (NASDAQ:ACET) shareholders have endured a 27% loss from investing in the stock a year ago (Simply Wall St.)
Nov-18-21 07:00AM	Adicet Announces Appointment of Dr. Michael G. Kauffman to the Board of Directors (GlobeNewswire)
Nov-12-21 07:00AM	Adicet Presents Preclinical Data for ADI-002, a GPC3-Targeted Development Candidate for Solid Tumors, at the SITC Annual Meeting (GlobeNewswire)
Nov-10-21 04:01PM	Adicet Reports Third Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Nov-08-21 07:00AM	Adicet Bio to Participate in Stifel 2021 Virtual Healthcare Conference (GlobeNewswire)
Nov-04-21 09:00AM	Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting (GlobeNewswire)
Oct-26-21 03:00AM	CDR-Life Announces Expansion of Scientific Advisory Board (GlobeNewswire)
Oct-12-21 04:10PM	Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer (GlobeNewswire)
Oct-04-21 07:00AM	Adicet to Present Preclinical Data from Allogeneic Gamma Delta T Cell Platform at SITC 36th Annual Meeting (GlobeNewswire)
Sep-13-21 08:00AM	Twist Bioscience Collaborates with Adicet Bio to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics (Business Wire)
08:00AM	Adicet Bio Collaborates with Twist Bioscience to Accelerate Discovery of Gamma Delta T Cell Cancer Therapeutics (GlobeNewswire)
Sep-02-21 04:53PM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-12-21 04:01PM	Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Aug-02-21 07:00AM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jul-30-21 10:35AM	Is Adicet Bio Inc. (ACET) A Good Stock To Buy? (Insider Monkey)
Jul-15-21 07:00AM	Adicet Bio Announces Formation of Scientific Advisory Board (GlobeNewswire)
Jun-28-21 07:00AM	Adicet Bio Added to the Russell 2000® Index (GlobeNewswire)
May-18-21 04:10PM	Adicet Bio to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-17-21 07:01AM	Adicet Reports First Quarter 2021 Financial Results and Provides Business Updates (GlobeNewswire)
Apr-29-21 07:00AM	Adicet Bio to Participate in Fireside Chat at the 7th Annual Truist Securities Life Sciences Summit (GlobeNewswire) +5.42%
Apr-15-21 07:00AM	Adicet Bio to Participate in the Canaccord Genuity 2021 Horizons in Oncology Virtual Conference (GlobeNewswire)
Apr-13-21 07:00AM	Adicet Bio Appoints Dr. Blake Aftab as Vice President of Research (GlobeNewswire)
Mar-11-21 04:10PM	Adicet Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update (GlobeNewswire)
Mar-10-21 07:00AM	Adicet Bio Announces Initiation of its First-in-Human Phase 1 Trial of ADI-001 for the Treatment of B Cell Non-Hodgkin's Lymphoma (PR Newswire)
Mar-04-21 04:01PM	Adicet Bio Appoints Dr. Andrew Sinclair to its Board of Directors (GlobeNewswire) -11.55%

Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and chimeric adaptors to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and enhance persistence for durable activity in patients. Its lead product in pipeline includes ADI-001, which is in Phase I clinical study for the treatment of non-Hodgkin's lymphoma. The company also develops ADI-002, which is undergoing preclinical studies for the treatment of various solid tumors; and ADI-925, a novel engineered CAd gamma delta T cell product candidate targeting tumor stress ligands. Adicet Bio, Inc. is based in Boston, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DUBIN STEVE	Director	Jun 30	Buy	2.40	5,000	12,000	10,900	Jun 30 04:08 PM
GORDON CARL L	Director	Jun 27	Buy	2.09	875,000	1,828,750	5,685,259	Jun 29 04:51 PM
ORBIMED ADVISORS LLC	Director	Jun 27	Buy	2.09	875,000	1,828,750	5,685,259	Jun 29 04:46 PM
Healey Don	Chief Technology Officer	Feb 15	Sale	7.57	4,533	34,327	66,568	Feb 17 08:22 PM
Healey Don	Chief Technology Officer	Feb 10	Sale	7.98	10,467	83,476	71,101	Feb 14 04:50 PM
Schor Chen	President & CEO	Nov 10	Sale	20.06	30,000	601,920	53,424	Nov 15 04:31 PM
Schor Chen	President & CEO	Nov 10	Sale	21.03	9,955	209,322	91,469	Nov 15 04:31 PM
Aftab Blake	Chief Scientific Officer	Nov 10	Sale	21.00	6,967	146,307	28,209	Nov 15 04:32 PM
Schor Chen	President & CEO	Nov 07	Sale	19.05	30,000	571,488	83,424	Nov 09 04:05 PM
Schor Chen	President & CEO	Nov 03	Sale	18.04	24,813	447,718	113,424	Nov 04 05:23 PM
Schor Chen	President & CEO	Nov 02	Sale	18.00	500	9,000	138,237	Nov 04 05:23 PM
Aftab Blake	Chief Scientific Officer	Oct 19	Sale	16.27	8,067	131,250	35,176	Oct 21 04:10 PM
Aftab Blake	Chief Scientific Officer	Oct 12	Option Exercise	7.38	3,388	25,003	52,822	Oct 14 04:08 PM
Aftab Blake	Chief Scientific Officer	Oct 12	Sale	15.40	1,646	25,348	51,176	Oct 14 04:08 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ACET | Adicet Bio, Inc.

Upgrade your FINVIZ experience